Found: 11
Select item for more details and to access through your institution.
Tumor-induced CD11b<sup>+</sup> Gr-1<sup>+</sup> myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
- Published in:
- European Journal of Immunology, 2015, v. 45, n. 4, p. 1148, doi. 10.1002/eji.201445093
- By:
- Publication type:
- Article
IFN-γ regulates survival and function of tumor-induced CD11b<sup>+</sup>Gr-1<sup>high</sup> myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.
- Published in:
- European Journal of Immunology, 2014, v. 44, n. 8, p. 2457, doi. 10.1002/eji.201444497
- By:
- Publication type:
- Article
Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0112717
- By:
- Publication type:
- Article
Harnessing High Density Lipoproteins to Block Transforming Growth Factor Beta and to Inhibit the Growth of Liver Tumor Metastases.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096799
- By:
- Publication type:
- Article
CD137 (4-1BB) costimulation of CD8<sup>+</sup> T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27613-w
- By:
- Publication type:
- Article
Hepatic myeloid-derived suppressor cells in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 931, doi. 10.1007/s00262-015-1736-y
- By:
- Publication type:
- Article
Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 717, doi. 10.1007/s00262-015-1681-9
- By:
- Publication type:
- Article
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32060-2
- By:
- Publication type:
- Article
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12998-6
- By:
- Publication type:
- Article
Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 963, doi. 10.3390/cancers13050963
- By:
- Publication type:
- Article
Characterization of woodchuck apolipoprotein A-I: A new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model.
- Published in:
- Journal of Medical Virology, 2011, v. 83, n. 7, p. 1221, doi. 10.1002/jmv.22104
- By:
- Publication type:
- Article